Evidence map›Paper›PMID 39877464›Full record

ArticleOphthalmology science

Glaucoma Detection and Feature Identification via GPT-4V Fundus Image Analysis.

Jalil Jalili, Anuwat Jiravarnsirikul, Christopher Bowd, Benton Chuter, Akram Belghith, Michael H Goldbaum, Sally L Baxter, Robert N Weinreb, Linda M Zangwill, Mark Christopher

Abstract read
In one paragraph

Article in Ophthalmology science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jalil JaliliDivision of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California, San Diego, La Jolla, California.
Anuwat JiravarnsirikulHamilton Glaucoma Center, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California, San Diego, La Jolla, California.
Christopher BowdDivision of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California, San Diego, La Jolla, California.
Benton ChuterDivision of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California, San Diego, La Jolla, California.
Akram BelghithDivision of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California, San Diego, La Jolla, California.
Michael H GoldbaumDivision of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California, San Diego, La Jolla, California.
Sally L BaxterDivision of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California, San Diego, La Jolla, California.
Robert N WeinrebDivision of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California, San Diego, La Jolla, California.
Linda M ZangwillDivision of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California, San Diego, La Jolla, California.
Mark ChristopherDivision of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California, San Diego, La Jolla, California.

Funding

Bridge2AI:Salutogenesis Data Generation ProjectOT2OD032644 · OD · WASHINGTON UNIVERSITY · PI BAXTER, SALLY LIU, CHUTE, CHRISTOPHER G · 2022 to 2025
$32.7M
Vision BiostatisticsP30EY022589 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Derek Stuart Welsbie · 2012 to 2026
$10.3M
Diagnostic Innovations in Glaucoma:Structural AssessmentR01EY011008 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZANGWILL, LINDA M · 1995 to 2015
$8.7M
xADAGES III: Contribution of genotype to glaucoma phenotype in African AmericansR01EY023704 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ROTTER, JEROME I, WEINREB, ROBERT N · 2013 to 2017
$6.3M
Diagnostic Innovations in Glaucoma Study (DIGS): High Myopia and Advanced DiseaseR01EY027510 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LINDA M ZANGWILL · 2017 to 2026
$5.3M
Ophthalmology and Visual Sciences Career Development K12 ProgramK12EY024225 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WEINREB, ROBERT N · 2015 to 2025
$4.3M
Diagnosis and Monitoring of Glaucoma with Optical Coherence Tomography AngiographyR01EY029058 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WEINREB, ROBERT N · 2018 to 2024
$4.2M
African Descent and Glaucoma Evaluation (ADAGES) II: Glaucoma ProgressionR01EY019869 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZANGWILL, LINDA M · 2010 to 2014
$2.8M
African Descent and Glaucoma Evaluation (ADAGES) IV: Alterations of the lamina cribrosa in progressionR01EY026574 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI FAZIO, MASSIMO ANTONIO, GIRKIN, CHRISTOPHER ANTHONY · 2017 to 2020
$2.6M
iGLAMOUR Study: Innovations in Glaucoma Adherence and monitoring Of Under-Represented minoritiesR01MD014850 · NIMHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI COLEMAN, TODD P, WEINREB, ROBERT N · 2021 to 2024
$2.1M
Multi-modal Health Information Technology Innovations for Precision Management of GlaucomaDP5OD029610 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BAXTER, SALLY LIU · 2020 to 2024
$2.1M
Multimodal Artificial Intelligence to Predict Glaucomatous Progression and Surgical InterventionR01EY034146 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BAXTER, SALLY LIU, CHRISTOPHER, MARK · 2022 to 2025
$1.8M
NEI NIH HHS K12 EY024225NEI NIH HHS P30 EY022589NEI NIH HHS R00 EY030942NEI NIH HHS R01 EY011008NEI NIH HHS R01 EY019869NEI NIH HHS R01 EY023704NEI NIH HHS R01 EY026574NEI NIH HHS R01 EY027510NEI NIH HHS R01 EY029058NEI NIH HHS R01 EY034146NEI NIH HHS R41 EY034424NEI NIH HHS T35 EY033704NIH HHS DP5 OD029610NIH HHS OT2 OD032644NIMHD NIH HHS R01 MD014850
6 · The paper itself

Abstract

Purpose: The aim is to assess GPT-4V's (OpenAI) diagnostic accuracy and its capability to identify glaucoma-related features compared to expert evaluations. Design: Evaluation of multimodal large language models for reviewing fundus images in glaucoma. Subjects: A total of 300 fundus images from 3 public datasets (ACRIMA, ORIGA, and RIM-One v3) that included 139 glaucomatous and 161 nonglaucomatous cases were analyzed. Methods: Preprocessing ensured each image was centered on the optic disc. GPT-4's vision-preview model (GPT-4V) assessed each image for various glaucoma-related criteria: image quality, image gradability, cup-to-disc ratio, peripapillary atrophy, disc hemorrhages, rim thinning (by quadrant and clock hour), glaucoma status, and estimated probability of glaucoma. Each image was analyzed twice by GPT-4V to evaluate consistency in its predictions. Two expert graders independently evaluated the same images using identical criteria. Comparisons between GPT-4V's assessments, expert evaluations, and dataset labels were made to determine accuracy, sensitivity, specificity, and Cohen kappa. Main Outcome Measures: The main parameters measured were the accuracy, sensitivity, specificity, and Cohen kappa of GPT-4V in detecting glaucoma compared with expert evaluations. Results: GPT-4V successfully provided glaucoma assessments for all 300 fundus images across the datasets, although approximately 35% required multiple prompt submissions. GPT-4V's overall accuracy in glaucoma detection was slightly lower (0.68, 0.70, and 0.81, respectively) than that of expert graders (0.78, 0.80, and 0.88, for expert grader 1 and 0.72, 0.78, and 0.87, for expert grader 2, respectively), across the ACRIMA, ORIGA, and RIM-ONE datasets. In Glaucoma detection, GPT-4V showed variable agreement by dataset and expert graders, with Cohen kappa values ranging from 0.08 to 0.72. In terms of feature detection, GPT-4V demonstrated high consistency (repeatability) in image gradability, with an agreement accuracy of ≥89% and substantial agreement in rim thinning and cup-to-disc ratio assessments, although kappas were generally lower than expert-to-expert agreement. Conclusions: GPT-4V shows promise as a tool in glaucoma screening and detection through fundus image analysis, demonstrating generally high agreement with expert evaluations of key diagnostic features, although agreement did vary substantially across datasets. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Indexed as

Artificial intelligenceFundus image analysisGlaucoma detectionGPT-4VLarge multimodal models

Identifiers

PMID39877464
PMCPMC11773068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.